Intracellular delivery of doxorubicin encapsulated in novel pH-responsive chitosan/heparin nanocapsules

36Citations
Citations of this article
75Readers
Mendeley users who have this article in their library.

Abstract

A novel polyelectrolyte nanocapsule system composed of biopolymers, chitosan and heparin has been fabricated by the layer-by-layer technique on silica nanoparticles followed by dissolution of the silica core. The nanocapsules were of the size range 200±20nm and loaded with the positively charged anticancer drug doxorubicin with an efficiency of 89%. The loading of the drug into the capsule happens by virtue of the pH-responsive property of the capsule wall, which is determined by the pKa of the polyelectrolytes. As the pH is varied, about 64% of the drug is released in acidic pH while 77% is released in neutral pH. The biocompatibility, efficiency of drug loading, and enhanced bioavailability of the capsule system was confirmed by MTT assay and in vivo biodistribution studies. © 2013 Thomas et al., publisher and licensee Dove Medical Press Ltd.

Cite

CITATION STYLE

APA

Thomas, M. B., Radhakrishnan, K., Gnanadhas, D. P., Chakravortty, D., & Raichur, A. M. (2013). Intracellular delivery of doxorubicin encapsulated in novel pH-responsive chitosan/heparin nanocapsules. International Journal of Nanomedicine, 8, 267–273. https://doi.org/10.2147/IJN.S37737

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free